1093:HKG
CSPC Pharmaceutical Group Ltd
7,00 HK$
arrow_downward
-1,27%(-0,090) 1D
9 հնս, 16:08:11 GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1093...
Open
7,09 HK$
High
7,19 HK$
Low
6,94 HK$
Mkt. cap
80,66 մլրդ
Avg. vol.
97,26 մլն
Volume
100,80 մլն
Dividend
4,14%
Quarterly dividend
0,07 HK$
Ex-dividend date
24 հնս, 2026 թ.
P/E ratio
21,17
52-wk high
11,63 HK$
52-wk low
6,64 HK$
EPS
0,33 HK$
Shares outstanding
11,52 մլրդ
No. of employees
20 հզր
Open
7,09 HK$
High
7,19 HK$
Low
6,94 HK$
Mkt. cap
80,66 մլրդ
Avg. vol.
97,26 մլն
Volume
100,80 մլն
Dividend
4,14%
Quarterly dividend
0,07 HK$
Ex-dividend date
24 հնս, 2026 թ.
P/E ratio
21,17
52-wk high
11,63 HK$
52-wk low
6,64 HK$
EPS
0,33 HK$
Shares outstanding
11,52 մլրդ
No. of employees
20 հզր
Analyst outlook
Analyst Ratings
Based on 15 analysts giving stock ratings to 1093 in the past 3 months
Buy
Buy
10
Hold
2
Sell
3
12 month forecast
Based on 15 Wall Street analysts offering 12 month price targets for 1093 in the last 3 months.
Highest
Current 7,00 HK$
19,36 HK$ (+176,57%)
Average
11,68 HK$ (+66,81%)
Lowest
6,00 HK$ (-14,29%)
News stories
From sources across the web
TipRanks
·
3 ժամ առաջ
CSPC Pharma Trustee Buys HK$15 Million in Shares for 2026 Award Scheme
TipRanks
·
1 օր առաջ
CSPC Pharmaceutical Expands 2026 Share Award Pool with On-Market Buy
TipRanks
·
1 օր առաջ
CSPC Wins U.S. FDA Nod for Once-Monthly Semaglutide Trial
Profile
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
About CSPC Pharmaceutical Group Ltd
AI content may include mistakes. Learn more